Neutropenic Enterocolitis and Sepsis: Towards the Definition of a Pathologic Profile

Abstract

Background: Neutropenic enterocolitis (NE), which in the past was also known as typhlitis or ileocecal syndrome for the segment of the gastrointestinal tract most affected, is a nosological entity that is difficult to diagnose and whose pathogenesis is not fully known to date. Initially described in pediatric patients with leukemic diseases, it has been gradually reported in adults with hematological malignancies and non-hematological conditions, such as leukemia, lymphoma, multiple myeloma, aplastic anemia, and also myelodysplastic syndromes, as well as being associated with other immunosuppressive causes such as AIDS treatment, therapy for solid tumors, and organ transplantation. Therefore, it is associated with high mortality due to the rapid evolution in worse clinical pictures: rapid progression to ischemia, necrosis, hemorrhage, perforation, multisystem organ failure, and sepsis. Case report: A case report is included to exemplify the clinical profile of patients with NE who develop sepsis. Literature Review: To identify a specific profile of subjects affected by neutropenic enterocolitis and the entity of the clinical condition most frequently associated with septic evolution, a systematic review of the literature was conducted. The inclusion criteria were as follows: English language, full-text availability, human subjects, and adult subjects. Finally, the papers were selected after the evaluation of the title and abstract to evaluate their congruity with the subject of this manuscript. Following these procedures, 19 eligible empirical studies were included in the present review. Conclusions: Despite the recent interest and the growing number of publications targeting sepsis and intending to identify biomarkers useful for its diagnosis, prognosis, and for the understanding of its pathogenesis, and especially for multi-organ dysfunction, and despite the extensive research period of the literature review, the number of publications on the topic “neutropenic enterocolitis and sepsis” appears to be very small. In any case, the extrapolated data allowed us to conclude that the integration of medical history, clinical and laboratory data, radiological imaging, and macroscopic and histological investigations can allow us to identify a specific pathological profile.

Forensic Diagnosis of Freshwater or Saltwater Drowning Using the Marker Aquaporin 5: An Immunohistochemical Study

“…The significant immunohistochemical hypo-expression of AQP5 in the samples of lungs and kidneys from FWD compared to those from SWD induces us to consider AQP5 as a reliable marker to which the pathologist may resort whenever dealing with the differential diagnosis between FWD and SWD [ 34 , 35 ]. The present study allows us to consider the immunohistochemical study of lung and renal tissues as a matter of paramount utility in the distinction between FWD and SWD, thus integrating the traditional forensic investigation [ 36 ].…”

Postmarketing Safety of Sacituzumab Govitecan: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System

“…39 Neutropenic colitis is a disease subtype difficult to distinguish diagnostically, and its underlying mechanism has yet to be fully understood. 40 Fabio et al reported that intestinal mucosal damage, along with neutropenia and weakened immune system of patients, may increase the risk of developing this disease. Chemotherapeutic drugs can directly damage the intestinal mucosa and increase the risk of such conditions.…”

A scoping review on acute gastrointestinal surgical complications in immunocompromised pediatric patients

“…Exposure to chemotherapy that induces mucositis and mucosal wall interruption and assists in bacterial translocation across the intestinal walls is hypothesized to be the main cause of this condition. Neutropenia exacerbates this bacterial spread following the weakened immune system's response against the infection [38]. Invasive fungal infections also seem to play a role and have been shown to increase mortality and morbidity in patients with NE.…”